Citation Impact
Citing Papers
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
Acyl-CoA-binding Protein Is a Potent m-Calpain Activator
2000
Molecular and Functional Properties of a Calpain Activator Protein Specific for μ-Isoforms
1998
Regulated import and degradation of a cytosolic protein in the yeast vacuole
1991 StandoutNatureNobel
Cell‐penetrating inhibitors of calpain block both membrane fusion and filamin cleavage in chick embryonic myoblasts
1993
The Bovine Calpastatin Gene Promoter and a New N-terminal Region of the Protein Are Targets for cAMP-dependent Protein Kinase Activity
1998
Peptide-binding specificity of the molecular chaperone BiP
1991 StandoutNatureNobel
Crystal structure of calcium bound domain VI of calpain at 1.9 Å resolution and its role in enzyme assembly, regulation, and inhibitor binding
1997
Autophagy and other vacuolar protein degradation mechanisms
1992
Properties of calpastatin forms in rat brain
1998
The mystery of nonclassical protein secretion
2003
Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart
2000
Myocardial calpain 2 is inhibited by monoclonal antibodies specific for the small noncatalytic subunit
1988
Pathophysiological role of calpain in experimental demyelination
1999
Purification of μ-Calpain by a Novel Affinity Chromatography Approach. NEW INSIGHTS INTO THE MECHANISM OF THE INTERACTION OF THE PROTEASE WITH TARGETS
1995
Dissociation of m-Calpain Subunits Occurs after Autolysis of the N-Terminus of the Catalytic Subunit, and Is Not Required for Activation
2001
Dephosphorylation and activation of Xenopusp34cdc2 protein kinase during the cell cycle
1989 StandoutNatureNobel
Cell-penetrating inhibitors of calpain
1991
cDNA Cloning of Human Calpastatin: Sequence Homology Among Human, Pig, and Rabbit Calpastatins
1989
All four internally repetitive domains of pig calpastatin possess inhibitory activities against calpains I and II
1987
Molecular cloning of the cDNA for the large subunit of the high-calcium-requiring form of human calcium-activated neutral protease
1988
On the mechanism of binding of calpastatin, the protein inhibitor of calpains, to biologic membranes
1988
Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease
1997
New era of calpain research
1994
A Spatial-Temporal Model of Cell Activation
1988 Science
Ca2+-Dependent Proteolytic Modification of the Camp-Dependent Protein Kinase in Drosophila Wild-Type and Dunce Memory Mutants
1989
A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat
1997
Mechanisms Underlying Long-Term Potentiation of Synaptic Transmission
1991
Characterization of Two Recombinant Drosophila Calpains
1999
Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin?
1992
Rat brain contains multiple mRNAs for calpastatin1
1998
Characterization of a functional domain of human calpastatin
1990
Neutrophil chemotactic activity of N-terminal peptides from the calpain small subunit
1990
Calcium-activated proteolysis of intracellular domains in the cell adhesion molecules NCAM and N-cadherin
1991
Regional and Temporal Alterations in Ca2+/Calmodulin‐Dependent Protein Kinase II and Calcineurin in the Hippocampus of Rat Brain After Transient Forebrain Ischemia
1992
Glutamate Neurotoxicity Is Independent of Calpain I Inhibition in Primary Cultures of Cerebellar Granule Cells
1991
Calpain activation is essential for membrane fusion of erythrocytes in the presence of exogenous Ca2+
1992
Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation
1990 StandoutNatureNobel
A novel aspect of calpain activation
1998
Procalpain I in cytoplasm is translocated onto plasma and granule membranes during platelet stimulation with thrombin and then activated on the membranes
1992
Free calcium and calpain I activity
1991
Fatty acylated proteins as components of intracellular signaling pathways
1990
Subcellular Localization and in VivoSubunit Interactions of Ubiquitous μ-Calpain
2003
Sequence comparison among muscle-specific calpain, p94, and calpain subunits
1992
Investigation of the interaction of m-calpain with phospholipids: calpain-phospholipid interactions
1996
Apoptotic mechanisms in the control of erythropoiesis
2004
Identification of a third ubiquitous calpain species — chicken muscle expresses four distinct calpains
1995
A synaptic model of memory: long-term potentiation in the hippocampus
1993 StandoutNature
'Oxidation Inhibits Substrate Proteolysis by Calpain I but Not Autolysis
1997
Local Cerebral Glucose Utilization and Cytoskeletal Proteolysis as Indices of Evolving Focal Ischemic Injury in Core and Penumbra
1995
A protein conjugation system essential for autophagy
1998 StandoutNatureNobel
Mechanism of action of the calpain activator protein in rat skeletal muscle
1991
Regulation of activity of calcium activated neutral protease
1988
The calpain-calpastatin system in obsessive-compulsive disorder
1997
Characterization of Three Components of Human Adenovirus Proteinase Activity in Vitro
1996
Structural Basis for Possible Calcium-Induced Activation Mechanisms of Calpains
2001
Colocalization of calcium-dependent protease II and one of its substrates at sites of cell adhesion
1987
Platelet Activation and Atherothrombosis
2007 Standout
A sarcolemma-associated inhibitor is capable of modulating calcium-dependent proteinase activity
1987
Determinants of the interindividual variability in response to antiplatelet drugs
2005
Calcium‐activated neutral proteinase (CANP; calpain) activity in Schwann cells: Immunofluorescence localization and compartmentation of μ‐ and mCANP
1991
Calpain activation in apoptosis
1994
Mitosis-specific phosphorylation of p60c-src by p34cdc2-associated protein kinase
1989 StandoutNobel
Binding sites for calcium-activated neutral protease on erythrocyte membranes are not membrane phospholipids
1990
Calpain and calpastatin regulate neutrophil apoptosis
1999
Proteolysis of tubulin and microtubule-associated proteins 1 and 2 by calpain I and II. Difference in sensitivity of assembled and disassembled microtubules
1988
Purification and characterization of a calpain activator from human platelets
1992
Immunohistochemical distribution of calcium‐activated neutral proteinases and endogenous CANP inhibitor in the rabbit hippocampus
1990
Autolysis of µ- and m-Calpain from Bovine Skeletal Muscle
2001
Ubiquitin C-Terminal Hydrolase Is an Immediate-Early Gene Essential for Long-Term Facilitation in Aplysia
1997 StandoutNobel
Inhibition of Calpain Blocks Platelet Secretion, Aggregation, and Spreading
1999
Muscle-Specific Calpain, p94, Interacts with the Extreme C-Terminal Region of Connectin, a Unique Region Flanked by Two Immunoglobulin C2 Motifs
1997
HIV infection does not require endocytosis of its receptor, CD4
1988 StandoutNobel
Calpains: Intact and active?
1997
cAMP contributes to mossy fiber LTP by initiating both a covalently mediated early phase and macromolecular synthesis-dependent late phase
1994 StandoutNobel
Persistent protein kinase activity underlying long-term potentiation
1988 Nature
Phosphorylation Modulates Calpain‐Mediated Proteolysis and Calmodulin Binding of the 200‐kDa and 160‐kDa Neurofilament Proteins
1993
Calpains and muscular dystrophies
2000
Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors
1991 StandoutNatureNobel
FMRFamide reverses protein phosphorylation produced by 5-HT and cAMP in Aplysia sensory neurons
1989 StandoutNatureNobel
The Structure of Calcium-Free Human m-Calpain Implications for Calcium Activation and Function
2001
Generation, Control, and Processing of Cellular Calcium Signals
2001
Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus
2015 StandoutNatureNobel
A catalytic subunit of calpain possesses full proteolytic activity
1995
Domain III of Calpain Is a Ca2+-Regulated Phospholipid-Binding Domain
2001
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Cortical Ablation Induces a Spreading Calcium-Dependent, Secondary Pathogenesis Which Can Be Reduced by Inhibiting Calpain
1999
Calpain-mediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes
2000
Low-Dose Aspirin for the Prevention of Atherothrombosis
2005
Structure of the Calmodulin αII-Spectrin Complex Provides Insight into the Regulation of Cell Plasticity
2006 StandoutNobel
PEST Sequences Do Not Influence Substrate Susceptibility to Calpain Proteolysis
1995
Purification of Active Calpain by Affinity Chromatography on an Immobilized Peptide Inhibitor
1996
Functional Properties of Recombinant Calpain I and of Mutants Lacking Domains III and IV of the Catalytic Subunit
1997
Cutting to the chase: calpain proteases in cell motility
2002
Characterization of Ca2+-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni
1993
Partial Purification and Characterization of a Ca2+-Dependent Proteinase fromArabidopsisRoots
1997
A BODIPY Fluorescent Microplate Assay for Measuring Activity of Calpains and Other Proteases
2000
Membrane Proximal ERK Signaling Is Required for M-calpain Activation Downstream of Epidermal Growth Factor Receptor Signaling
2001
Properties and Intracellular Localization of Calpain Activator Protein
2000
Domain II of m‐calpain is a Ca2+‐dependent cysteine protease
2001
Activation of calpain I and calpain II: A comparative study using terbium as a fluorescent probe for calcium-binding sites
1988
An Improved Purification Procedure for Calpastatin, the Inhibitor Protein Specific for the Intracellular Calcium-Dependent Proteinases, Calpains
1988
Modulation of rat brain calpastatin efficiency by post‐translational modifications
1997
A ubiquitin-like system mediates protein lipidation
2000 StandoutNatureNobel
Immunocytochemical localization of Ca2+‐dependent protease from Allomyces arbuscula
1994
A variety of calpain/calpastatin systems in mammalian erythrocytes
1993
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
The binding of large calpastatin to biologic membranes is mediated in part by interaction of an amino terminal region with acidic phospholipids
1989
Pig heart calpastatin: identification of repetitive domain structures and anomalous behavior in polyacrylamide gel electrophoresis
1988
The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B
1988
Degradation of nuclear oncoproteins by the ubiquitin system in vitro.
1991 StandoutNobel
Characterization of cDNA clones encoding a novel calcium-activated neutral proteinase from Schistosoma mansoni
1991
Ca(2+)-activated neutral protease is active in the erythrocyte membrane in its nonautolyzed 80-kDa form.
1994
The mouse and human genes encoding the recognition component of the N-end rule pathway
1998 StandoutNobel
Association of calpain (Ca2+-dependent thiol protease) with its endogenous inhibitor calpastatin in myoblasts
1999
Isolated bovine myocardial sarcolemma and sarcoplasmic reticulum vesicles contain tightly bound calcium-dependent protease inhibitor
1987
CalpA, a Drosophila Calpain Homolog Specifically Expressed in a Small Set of Nerve, Midgut, and Blood Cells
1995
Degradation of Proteins with Acetylated Amino Termini by the Ubiquitin System
1989 StandoutScienceNobel
Cytoplasm-to-vacuole targeting and autophagy employ the same machinery to deliver proteins to the yeast vacuole.
1996 StandoutNobel
Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system
1996
Serotonin-Mediated Endocytosis of apCAM: an Early Step of Learning-Related Synaptic Growth in Aplysia
1992 StandoutScienceNobel
Regulation of synthesis and degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by low density lipoprotein and 25-hydroxycholesterol in UT-1 cells.
1982 StandoutNobel
c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock.
1988
Role of arginine-tRNA in protein degradation by the ubiquitin pathway
1987 StandoutNatureNobel
The tra-3 sex determination gene of Caenorhabditis elegans encodes a member of the calpain regulatory protease family.
1996
Calpain II Involvement in Mitosis
1988 Science
Purification and structural studies of a major scrapie prion protein
1984 StandoutNobel
Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction.
1992 StandoutNobel
Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling
2006
Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein.
1987
Purification and characterization of a protein inhibitor of calcium-dependent proteases from rat liver
1984
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
1976 Standout
Molar absorptivity and A1cm1% values for proteins at selected wavelengths of the ultraviolet and visible regions. VIII
1973
Properties of erythrocyte membrane binding and autolytic activation of calcium-activated neutral protease
1989
In situ Phosphorylation of Platelet Actin-binding Protein by cAMP-dependent Protein Kinase Stabilizes It against Proteolysis by Calpain
1989
Preferential degradation of the oxidatively modified form of glutamine synthetase by intracellular mammalian proteases.
1985
Spectrin is associated with membrane-bound actin filaments in platelets and is hydrolyzed by the Ca2+-dependent protease during platelet activation
1987
ATG Systems from the Protein Structural Point of View
2009 StandoutNobel
Autolysis parallels activation of μ-calpain
1996
Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa.
1993
Calpain inhibitors as potential treatment for stroke and other neurodegenerative diseases: recent trends and developments
1998
Impaired Long-Term Potentiation, Spatial Learning, and Hippocampal Development in fyn Mutant Mice
1992 StandoutScienceNobel
Degradation from the endoplasmic reticulum: Disposing of newly synthesized proteins
1988
Calcium-activated protease in the giant algaChara australis
1987
Allomyces Ca2+-activated neutral protease: Interaction with phospholipids and plasma membranes
1989
Tracking the flow of learned information from membrane receptors to genome
1986 StandoutNobel
Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger.
1991 StandoutNobel
Reversible interaction between Ca2+‐activated neutral protease (CANP) and its endogenous inhibitor
1985
Calpain Regulates Actin Remodeling during Cell Spreading
1998
The Calpain System
2003 Standout
Purification of an 11 S regulator of the multicatalytic protease.
1992
Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and μ-types
1989
The Ca2+-activated protease (calpain) modulates Ca2+/calmodulin dependent activity of smooth muscle myosin light chain kinase
1987
Molecular cloning of 3-hydroxy-3-methylglutaryl coenzyme a reductase and evidence for regulation of its mRNA.
1982 StandoutNobel
Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration.
1993
Proteinase K from Tritirachium album Limber
1974
Structure and physiological function of calpains
1997
Calmodulin Regulates Fodrin Susceptibility to Cleavage by Calciumdependent Protease I
1989
MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence
2003 StandoutNobel
Affinity labelling of the Ca2+-activated neutral proteinase (calpain) in intact human platelets
1993
In vitro and in vivo phosphorylation of calpain-like protease of Allomyces arbuscula
1991
Microtubular Proteolysis in Focal Cerebral Ischemia
1996
Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
1995 StandoutNobel
Red blood cells contain a pathway for the degradation of oxidant-damaged hemoglobin that does not require ATP or ubiquitin.
1986
UBIQUITIN-DEPENDENT PROTEIN DEGRADATION
1996
Proteinase involvement in the solubilization of 3-hydroxy-3-methylglutaryl coenzyme a reductase
1981
Proteolysis of the calcium-dependent protease inhibitor by myocardial calcium-dependent protease
1986
Activation of multiple protein kinases during the burst in protein phosphorylation that precedes the first meiotic cell division in Xenopus oocytes.
1988
In Vivo Half-Life of a Protein Is a Function of Its Amino-Terminal Residue
1986 StandoutScience
Calcium‐dependent proteases: an enzyme system active at cellular membranes?
1987
Studies and Perspectives of Protein Kinase C
1986 StandoutScience
Calcium-activated neutral protease inhibitor from rabbit erythrocytes lacks the N-terminal region of the liver inhibitor but retains three inhibitory units
1987
In vitro proteolysis of brain spectrin by calpain I inhibits association of spectrin with ankyrin-independent membrane binding site(s).
1991
Phosphorylation and subcellular distribution of calpastatin in human hematopoietic system cells
1991
Ischemic Cell Death in Brain Neurons
1999 Standout
Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes.
1990 StandoutNobel
Protein damage and degradation by oxygen radicals. I. general aspects.
1987 Standout
Analysis of structure-function relationship of pig calpastatin by expression of mutated cDNAs in Escherichia coli.
1988
The Calpain Hypothesis of Neurodegeneration: Evidence for a Common Cytotoxic Pathway
1997
Repetitive region of calpastatin is a functional unit of the proteinase inhibitor
1987
Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold increase in 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
1982 StandoutNobel
Monocyte responses to sulfatide from Mycobacterium tuberculosis: inhibition of priming for enhanced release of superoxide, associated with increased secretion of interleukin-1 and tumor necrosis factor alpha, and altered protein phosphorylation
1991
Roles of individual EF-hands in the activation of m-calpain by calcium
2000
The role of autolysis in activity of the Ca2+-dependent proteinases (μ-calpain and m-calpain)
1989
Procalpain is activated on the plasma membrane and the calpain acts on the membrane
1987
Calcium‐activated neutral protease and its endogenous inhibitor Activation at the cell membrane and biological function
1987
Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy.
1994 StandoutNobel
Calcium · calmodulin-dependent protein kinase II and calcium · phospholipid-dependent protein kinase activities in rat tissues assayed with a synthetic peptide
1987
Identification of Major Autolytic Cleavage Sites in the Regulatory Subunit of Vascular Calpain II
1989
Molecular cloning and analysis of small optic lobes, a structural brain gene of Drosophila melanogaster.
1991
In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets
2005
Rapid microassay for protein kinase C translocation in Swiss 3T3 cells
1986 StandoutNobel
Expression of a constitutively activated mutant of the beta-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the beta-myosin heavy chain isogene
1991
Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway
1998 StandoutNobel
Peptide sequences that target proteins for enhanced degradation during serum withdrawal.
1988
Effect of Ca2+ on binding of the calpains to calpastatin
1989
In Vivo Stimulation of IκB Phosphorylation Is Not Sufficient To Activate NF-κB
1995
Unconventional Secretion, Unconventional Solutions
2013 StandoutScienceNobel
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Lipid modifications of G proteins: alpha subunits are palmitoylated.
1993 StandoutNobel
Scanning the human proteome for calmodulin-binding proteins
2005 StandoutNobel
c-myc and c-myb Protein Degradation: Effect of Metabolic Inhibitors and Heat Shock
1988
Positive regulation of mu-calpain action by polyphosphoinositides.
1992
A novel tissue-specific calpain species expressed predominantly in the stomach comprises two alternative splicing products with and without Ca(2+)-binding domain.
1993
Purification of native p94, a muscle-specific calpain, and characterization of its autolysis
1998
Effect of monoclonal antibodies specific for the 28-kDa subunit on catalytic properties of the calpains.
1993
Modulation of an NCAM-Related Adhesion Molecule with Long-Term Synaptic Plasticity in Aplysia
1992 StandoutScienceNobel
Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene
1989
Works of E. Melloni being referenced
Vincristine-resistant erythroleukemia cells have marked increased sensitivity to hexamethylene bisacetamide induced differentiation.
1988
Effects of a monoclonal anti-calpain antibody on responses of stimulated human neutrophils. Evidence for a role for proteolytically modified protein kinase C.
1988
Biochemical responses in activated human neutrophils mediated by protein kinase C and a Ca2+-requiring proteinase.
1986
The involvement of calpain in the activation of protein kinase C in neutrophils stimulated by phorbol myristic acid.
1986
Modulation of inhibitory efficiency of rat skeletal muscle calpastatin by phosphorylation
1992
The plasma membrane calcium pump is the preferred calpain substrate within the erythrocyte
1994
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension
1988
Phosphorylation of rat brain calpastatins by protein kinase C
1999
Reversible Inactivation of Calpain Isoforms by Nitric Oxide
1995
Modulation of Calpastatin Specificity in Rat Tissues by Reversible Phosphorylation and Dephosphorylation
1994
Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms
1990
Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation
1997
Activation of neutrophil calpain following its translocation to the plasma membrane induced by phorbol ester or fMet-Leu-Phe
1989
The calpain-calpastatin system in mammalian cells: properties and possible functions
1992
Modulation of the Calpain Autoproteolysis by Calpastatin and Phospholipids
1996
Identification of an endogenous activator of calpain in rat skeletal muscle
1990
Activation by hemoglobin of the Ca2+-requiring neutral proteinase of human erythrocytes: Structural requirements
1984
Characterization of the defective calpain-endogenous calpain inhibitor system in erythrocytes from Milan hypertensive rats
1986
Characterization of three rabbit liver lysosomal proteinases with fructose 1,6-bisphosphatase converting enzyme activity
1981
Site-directed activation of calpain is promoted by a membrane-associated natural activator protein
1993
Regulation of the Ca2+-dependent neutral proteinases from rabbit liver by an endogenous inhibitor
1984
Introduction of the beta isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells.
1990
Phosphorylation by protein kinase C of a 20-kDa cytoskeletal polypeptide enhances its susceptibility to digestion by calpain.
1987
Identification of the proteolytically activated form of protein kinase C in stimulated human neutrophils.
1990
Reversible activation of human neutrophil calpain promoted by interaction with plasma membranes.
1985
Two cytosolic, Ca2+-dependent, neutral proteinases from rabbit liver: Purification and properties of the proenzymes
1984
Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation.
1988
Rabbit liver fructose 1,6-diphosphatase. Properties of the native enzyme and their modification by subtilisin
1972
TRAIL regulates normal erythroid maturation through an ERK-dependent pathway
2003
Cytosolic Ca2+-dependent neutral proteinases from rabbit liver: activation of the proenzymes by Ca2+ and substrate.
1984
Binding to erythrocyte membrane is the physiological mechanism for activation of Ca2+-dependent neutral proteinase
1985
The calpains
1989
Differential mechanisms of translocation of protein kinase C to plasma membranes in activated human neutrophils
1986
Binding of protein kinase C to neutrophil membranes in the presence of Ca2+ and its activation by a Ca2+-requiring proteinase.
1985
Cytosolic calcium dependent neutral proteinase of human erythrocytes: The role of calcium ions on the molecular and catalytic properties of the enzyme
1982
Cytosolic calcium dependent proteinase of human erythrocytes: Formation of an enzyme-natural inhibitor complex induced by Ca2+ ions
1982
Isovalerylcarnitine is a specific activator of calpain of human neutrophils
1987
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
2002
EXTRALYSOSOMAL PROTEIN DEGRADATION
1986
Decreased level of calpain inhibitor activity in red blood cells from Milan hypertensive rats
1986
Specific degradation of troponin T and I by μ-calpain and its modulation by substrate phosphorylation
1995
Isozymes of protein kinase C in human neutrophils and their modification by two endogenous proteinases.
1990
Role of phospholipids in the activation of the Ca2+-dependent neutral proteinase of human erythrocytes
1985
An endogenous activator of the Ca2+-dependent proteinase of human neutrophils that increases its affinity for Ca2+.
1988
Erythrocyte deficiency in calpain inhibitor activity in essential hypertension.
1988
Ligand-induced conformational states of rabbit liver fructose 1,6-bisphosphatase as revealed by digestion with subtilisin
1973
A dual role for the Ca2+-requiring proteinase in the degradation of hemoglobin by erythrocyte membrane proteinases.
1984